David E. Espinoza

92-94 Parramatta Road
Camperdown, VIC 2050, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

Journal: Future oncology (London, England)

Published: June 16, 2026

Characteristics of Participants Screened and Randomized to the Melanoma Self Surveillance Trial.

Characteristics of Participants Screened and Randomized to the Melanoma Self Surveillance Trial.

Journal: JAMA dermatology

Published: March 11, 2026

Genomic Therapy Matching in Rare and Refractory Cancers.

Genomic Therapy Matching in Rare and Refractory Cancers.

Journal: JAMA oncology

Published: March 05, 2026

Time trends in the incidence of multiple primary melanomas in Australia.

Time trends in the incidence of multiple primary melanomas in Australia.

Journal: Cancer epidemiology

Published: February 27, 2026

Prevalence and correlates of clinical skin checks for skin cancer among Australians.

Prevalence and correlates of clinical skin checks for skin cancer among Australians.

Journal: Cancer epidemiology

Published: January 07, 2026

NeuroMusic: protocol for a randomised-controlled trial of keyboard and singing music training programmes for older adults with mild cognitive impairment.

NeuroMusic: protocol for a randomised-controlled trial of keyboard and singing music training programmes for older adults with mild cognitive impairment.

Journal: BMJ open

Published: December 08, 2025

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial.

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial.

Journal: Nature medicine

Published: September 05, 2025

A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 04, 2025

Real-world evaluation of the use of melanoma risk prediction tools by clinicians in Australia: a mixed methods study.

Real-world evaluation of the use of melanoma risk prediction tools by clinicians in Australia: a mixed methods study.

Journal: The British journal of dermatology

Published: August 25, 2025

Evaluating missing outcome data methods for the analysis of the MEL-SELF trial of patient-led surveillance for early-stage melanoma: A simulation study.

Evaluating missing outcome data methods for the analysis of the MEL-SELF trial of patient-led surveillance for early-stage melanoma: A simulation study.

Journal: Contemporary clinical trials

Published: August 06, 2025

Development and validation of a prognostic model incorporating patient reported outcomes for advanced gastric and esophageal carcinoma (AGOC) using individual patient data from two AGITG randomized clinical trials.

Development and validation of a prognostic model incorporating patient reported outcomes for advanced gastric and esophageal carcinoma (AGOC) using individual patient data from two AGITG randomized clinical trials.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: June 13, 2025

High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD).

High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD).

Journal: British journal of cancer

Published: April 04, 2025

Showing 1-12 of 67

Last Updated: 09/26/2026